Perturbations du comportement secondaires aux troubles neurocognitifs (SCPD) : Évaluation et prise en charge globale #102

Herrmann, N., Gauthier, S., Boneva, N., Lemming, O.M. & 10158 Investigators. (2013). A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer’s disease. Int Psychogeriatr, 25(6), 919-27. doi: 10.1017/S1041610213000239.